The Human ImmunoPhenotyping Initiative (HIPI) aims to advance precision immunomedicine for the benefit of patients with hard-to-treat and incurable conditions, ranging from autoimmune diseases to neurodegenerative disorders. Our goal is to customize medical decisions, treatments, and practices for individual patients based on their unique immune phenotype – their personal immune fingerprint.

By providing funding support for our expert clinical and translational immunological investigators, we can together help ensure the correct medical treatments reach the correct patients at the correct time.

HIPI is currently soliciting applications to its Translational Research Seed Funding Program. Interested faculty should review the Request for Proposals, available here (insert link).

We are also looking to add to our passionate and dedicated team and are hiring a Clinical Research Coordinator and a Program Manager.

The HIPI mission is made possible by funding from the Beirne Carter Foundation.